As of 2024-10-12, the Relative Valuation of Eli Lilly and Co (LLY) is 244.52 USD. This relative valuation is based on P/E multiples. With the latest stock price at 932.06 USD, the upside of Eli Lilly and Co based on Relative Valuation is -73.8%.
The range of the Relative Valuation is 163.92 - 279.19 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 36.1x | 33.9x |
| Forward P/E multiples | 23.0x - 33.4x | 31.9x |
| Fair Price | 163.92 - 279.19 | 244.52 |
| Upside | -82.4% - -70.0% | -73.8% |
| Date | P/E |
| 2024-10-11 | 120.65 |
| 2024-10-10 | 117.89 |
| 2024-10-09 | 119.06 |
| 2024-10-08 | 118.28 |
| 2024-10-07 | 116.30 |
| 2024-10-04 | 114.84 |
| 2024-10-03 | 114.63 |
| 2024-10-02 | 115.35 |
| 2024-10-01 | 114.49 |
| 2024-09-30 | 114.68 |
| 2024-09-27 | 113.63 |
| 2024-09-26 | 117.71 |
| 2024-09-25 | 119.68 |
| 2024-09-24 | 119.67 |
| 2024-09-23 | 118.90 |
| 2024-09-20 | 119.28 |
| 2024-09-19 | 118.45 |
| 2024-09-18 | 117.15 |
| 2024-09-17 | 117.30 |
| 2024-09-16 | 119.55 |
| 2024-09-13 | 119.57 |
| 2024-09-12 | 121.04 |
| 2024-09-11 | 119.21 |
| 2024-09-10 | 116.66 |
| 2024-09-09 | 117.57 |
| 2024-09-06 | 116.85 |
| 2024-09-05 | 118.15 |
| 2024-09-04 | 122.50 |
| 2024-09-03 | 123.82 |
| 2024-08-30 | 124.27 |
| 2024-08-29 | 121.71 |
| 2024-08-28 | 122.84 |
| 2024-08-27 | 123.56 |
| 2024-08-26 | 123.04 |
| 2024-08-23 | 123.33 |
| 2024-08-22 | 123.51 |
| 2024-08-21 | 123.23 |
| 2024-08-20 | 122.97 |
| 2024-08-19 | 119.33 |
| 2024-08-16 | 119.37 |
| 2024-08-15 | 120.59 |
| 2024-08-14 | 120.60 |
| 2024-08-13 | 117.54 |
| 2024-08-12 | 114.48 |
| 2024-08-09 | 115.43 |
| 2024-08-08 | 109.42 |
| 2024-08-07 | 99.95 |
| 2024-08-06 | 102.68 |
| 2024-08-05 | 100.36 |
| 2024-08-02 | 104.14 |